FeesSafety
Pluang+

Beam Therapeutics remains a long-term buy with strong 2028-29 upside from gene editing advances.

Analyst Insights
29 Sep 2026
Seeking Alpha
View Source
Bullish
Beam Therapeutics remains a long-term buy with strong 2028-29 upside from gene editing advances.

Beam Therapeutics is reaffirmed as a long-term buy due to its leadership in gene editing, particularly with its AATD treatment BEAM-302, expected to drive significant growth around 2028-2029. While the blockbuster potential of Risto-cel has been downgraded, Beam's first-mover advantage in base editing and potential AI partnerships support its future prospects. The company has a cash runway of 2-3 years but may face dilution before generating meaningful revenue. Overall, its valuation is fair compared to peers given the pipeline risks and innovation potential.

Beam Therapeutics is the subject of this update, with Pluang providing relevant market data for context. As of Sep 29, 2026 18:14 WIB, 44 of 100 priced Health-sector US stocks on Pluang rose while 49 fell. Notable movers include AZN at USD 168.27 with a 1-day change of +1.28%, AMLX at USD 29.50 down 1.17%, and INCY at USD 126.20 up 1.11%.

More News

Compound (COMP) token drops 7.53% in 24 hours amid $2.4M trading volume

Compound (COMP) token drops 7.53% in 24 hours amid $2.4M trading volume

The Compound (COMP) cryptocurrency token fell by 7.53% over a 24-hour period as of October 25. During this time, its price fluctuated between $21.33 and $24.99. The total trading volume recorded was approximately $2.4 million. This decline reflects m...

Market News
Bearish
4 hours ago
Mastercard praises Ripple's RLUSD stablecoin at XRPL Commons Hackathon, but no new product launch announced.

Mastercard praises Ripple's RLUSD stablecoin at XRPL Commons Hackathon, but no new product launch announced.

At the XRPL Commons Hackathon in New York, Mastercard representatives reportedly praised Ripple's RLUSD stablecoin during a partner pitch session, according to an attendee's account. The event, held on October 24–25, featured Mastercard as a partner ...

Market News
Neutral
4 hours ago
Whirlpool's dividend cut warns investors about risks in 3 high-yield stocks showing similar financial stress.

Whirlpool's dividend cut warns investors about risks in 3 high-yield stocks showing similar financial stress.

Whirlpool abruptly cut its dividend to zero in early 2026 after years of reliable payouts, highlighting risks in high-yield stocks. Three popular stocks—Clorox, General Mills, and Ford—show warning signs like dividends exceeding earnings, declining f...

Market News
Bearish
4 hours ago
Kraken's parent Payward gets preliminary approval to expand trading and custody in Kazakhstan.

Kraken's parent Payward gets preliminary approval to expand trading and custody in Kazakhstan.

Payward, the parent company of cryptocurrency exchange Kraken, has received in-principle approval to expand its operations into Kazakhstan. This preliminary approval covers trading and custody services, marking a significant step forward in Payward's...

Market News
Neutral
4 hours ago
Circle minted $250M USDC on Solana blockchain in a major digital asset transaction.

Circle minted $250M USDC on Solana blockchain in a major digital asset transaction.

Circle minted 250 million USDC tokens on the Solana blockchain on October 25, a transaction worth about $250 million confirmed on the network. USDC is a stable digital token used for transactions, and Solana is a popular blockchain platform for digit...

Protocol Fundamentals
Neutral
4 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App